n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine has been researched along with 2-naphthylamine in 7 studies
| Studies (n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine) | Trials (n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine) | Recent Studies (post-2010) (n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine) | Studies (2-naphthylamine) | Trials (2-naphthylamine) | Recent Studies (post-2010) (2-naphthylamine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 1,448 | 46 | 508 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyadjiev, T; Mihaylova, S; Raynova, L; Staneva-Stoycheva, D; Tomov, T | 1 |
| Mutafova-Yambolieva, V; Staneva-Stoytcheva, D | 2 |
| Mutafova-Iambolieva, V; Staneva-Stoĭcheva, D | 1 |
| Bogoslovova, T; Staneva-Stoĭcheva, D | 1 |
| De Haan, BJ; De Vos, P; Van Schilfgaarde, R | 2 |
7 other study(ies) available for n-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)piperazine and 2-naphthylamine
| Article | Year |
|---|---|
On the antiarrhythmic activity of one N-substituted piperazine derivative of trans-2-amino-3-hydroxy-1, 2, 3, 4-tetrahydroanaphthalene.
Topics: 2-Naphthylamine; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Cats; Erythrocyte Membrane; Humans; In Vitro Techniques; Microsomes, Liver; Naphthalenes; Oxidative Phosphorylation; Rabbits; Rats; Time Factors | 1979 |
Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
Topics: 2-Naphthylamine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Phentolamine; Rats; Rats, Inbred Strains; Trachea | 1988 |
Involvement of peripheral dopaminergic mechanisms in the action of a 2-piperazinotetralin (P-11) with hypotensive activity.
Topics: 2-Naphthylamine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Dinoprost; Electric Stimulation; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Rabbits; Receptors, Dopamine; Sulpiride; Synaptic Transmission; Vasoconstriction | 1988 |
[Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
Topics: 2-Naphthylamine; Animals; Antihypertensive Agents; Blood Pressure; Cats; Dose-Response Relationship, Drug; Drug Interactions; Male; Naphthalenes; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1985 |
[Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations].
Topics: 2-Naphthylamine; Animals; Antihypertensive Agents; Brain; In Vitro Techniques; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthalenes; Propranolol; Rats; Rats, Inbred Strains; Selegiline; Tetrahydronaphthalenes | 1987 |
Is it possible to use the standard alginate-PLL procedure for production of small capsules?
Topics: 2-Naphthylamine; Animals; Biocompatible Materials; Capsules; Organ Transplantation; Rats | 1998 |
Factors causing failure of islets in nonovergrown capsules.
Topics: 2-Naphthylamine; Animals; Biocompatible Materials; Capsules; Diabetes Mellitus, Experimental; Graft Rejection; Islets of Langerhans Transplantation; Rats; Rats, Inbred Lew | 1998 |